Form 4 Filing for BIOMARIN PHARMACEUTICAL INC

2026-06-04SEC Filing 4 (0001628280-26-040909)

This Form 4 filing reports a transaction by CLARK IAN T, who is a director at BIOMARIN PHARMACEUTICAL INC. On June 2, 2026, Mr. Clark acquired 7,490 shares of Common Stock through a grant of restricted stock units. The transaction code "A" indicates an acquisition, and the price per share is noted as not applicable, with a footnote referencing the restricted stock units granted on that date. Following this transaction, Mr. Clark now owns 14,490 shares of Common Stock. The filing is made on June 4, 2026, and is signed by Tae Sang Yoo as Attorney-in-Fact.